Claim 70% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
An update from Invex Therapeutics Ltd. ( (AU:IXC) ) is now available.
Invex Therapeutics Ltd has announced that its 2025 Annual General Meeting will be held virtually on November 25, 2025. Shareholders can access the Notice of Meeting and related materials online, and voting will be conducted via proxy. The virtual format and online access to materials reflect the company’s adaptation to modern communication methods, potentially increasing accessibility and engagement among shareholders.
More about Invex Therapeutics Ltd.
Invex Therapeutics Ltd is a company operating in the biotechnology industry, focusing on the development of therapeutic treatments. The company is listed on the Australian Securities Exchange under the code IXC.
Average Trading Volume: 72,932
Technical Sentiment Signal: Buy
Current Market Cap: A$7.89M
For detailed information about IXC stock, go to TipRanks’ Stock Analysis page.